“Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b 3, Double-Blind, Placebo-Controlled Study”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s103. https://doi.org/10.25251/skin.6.supp.103.